![](https://siapsprogram.org/wp-content/uploads/2019/11/Protocol-and-Operational-Plan_Development-of-Sustainable-HIV-TB-Active-Surveillance-System-in-Swaziland_Page_01-100x130.png)
A pharmacovigilance system, through active surveillance in sentinel sites, is proposed to monitor the safety and tolerability of antiretroviral medicines (ARV) and anti-tuberculosis (TB) medicines at antiretroviral treatment (ART) clinics and TB clinics in Swaziland. The goal of this activity is to develop, implement, and demonstrate the local feasibility of a practical and sustainable pharmacovigilance system that could later be scaled up to monitor the safety of ARV and TB regimens throughout the country.
- Development of Sustainable HIV/TB Active Surveillance System in Swaziland – Protocol and Operational Plan — View | Download